ArticleJournal of the Endocrine Society2026
Impact of idiopathic short stature on children's well-being: a nationwide study of short Danish children.
Article in Journal of the Endocrine Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Context: It remains unclear whether idiopathic short stature (ISS), defined as a height below -2.0 SD score (SDS) without an identifiable cause, adversely affects psychosocial well-being. Objective: To assess the psychosocial impact of ISS in children using nationwide registry and survey data. Design: The nationwide cohort study included children identified between 2012 and 2020 with follow-up questionnaire data up until 2022. Setting: School-aged children in Denmark. Patients or Other Participants: The National Child Health Register contained heights on 507 754 children of which 42 185 had heights below -2.0 SDS. Children with a diagnostic code associated with potential underlying causes for short stature in the Danish National Patient Registry were excluded. The final cohort included 16 121 children with ISS. Each child was matched to 5 controls by age, sex, and region. Interventions: None. Main Outcome Measures: Psychosocial well-being (bullying, loneliness, and insecurity) assessed by mandatory National Well-being Surveys (2015-2022). Odds ratios (ORs) were calculated across school grade levels. Results: Children with ISS had higher odds of feeling bullied (school grade levels 0-3: OR 1.03 [95% confidence interval (CI) 0.95-1.12]; 4-6: OR 1.37 [95% CI 1.24-1.56]; 7-9: OR 1.19 [95% CI 1.02-1.40]), lonely (0-3: OR 1.02 [95% CI 0.93-1.12]; 4-6: OR 1.15 [95% CI 1.06-1.27]; 7-9: OR 1.11 [95% CI 1.01-1.25]), and insecure (0-3: OR 1.08 [95% CI 1.00-1.17]; 4-6: OR 1.07 [95% CI 1.02-1.15]; 7-9: OR 1.09 [95% CI 1.04-1.19]). Conclusion: Children with ISS displayed increased psychosocial distress. These findings support psychosocial assessment in children with ISS to enable timely intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.